Focus: EchoNous develops ultrasound diagnostic devices and algorithms, with a focus on bladder scanning and cardiac applications in cardiovascular and nephrology markets. The company operates as a specialized medical device innovator rather than a traditional pharmaceutical manufacturer.
Profile data last refreshed 12h ago · AI intelligence enriched 2mo ago
Stable — net +1 jobs in 30d
6 added, 5 removed. Backfill posture.
EchoNous represents a specialized device/algorithm play with technical merit but material hiring and financial visibility risks that warrant direct due diligence before committing.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for EchoNous
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from EchoNous's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo